Advertisement

Committee Connection

Bloggers


 
Clement A. Adebamowo, MD, ScD, is an Associate Professor in the Department of Epidemiology and Preventive Medicine within the School of Medicine & Institute of Human Virology at the University of Maryland, Director of the Office of Strategic Information and Research Institute of Human Virology in Nigeria, and serves on the Editorial Boards of the Journal of Clinical Oncology and the Annals of Surgical Oncology. He previously served as Chair of ASCO's International Affairs Committee. Follow Dr. Adebamowo on Twitter @adebamowo.
   

Edward P. Balaban, DO, FACP, FASCO, is a community hematologist/oncologist at Heritage Valley Hematology and Medical Oncology, Pennsylvania, and a staff member at the University of Pittsburgh Medical Center Cancer Clinics. He has served ASCO as Editor of both the JCO and JOP, as a member of the Clinical Practice Committee and Clinical Practice Guideline Committee, as a panel member for guidelines on venous thromboembolism and chemotherapy dosing; he also served as Chair of the Guideline Implementation Network (PGIN). Dr. Balaban is Past President of the Pennsylvania Society of Oncology and Hematology and is the alternate delegate representing ASCO at the AMA-House of Delegates.
   

Jonathan S. Berek, MD, MMS, FASCO, is Editor-in-Chief of ASCO Connection. Dr. Berek is the Laurie Kraus Lacob Professor and Director of the Stanford Women's Cancer Center at the Stanford Cancer Institute, where he specializes in gynecologic oncology, and Chair of the Department of Obstetrics and Gynecology at Stanford University School of Medicine. Dr. Berek currently serves on ASCO's Scientific Program Committee and Integrated Media and Technology Committee. He has been Editor-in-Chief of ASCO Connection (previously ASCO News & Forum) since 2004.
   
   

Douglas W. Blayney, MD, FASCO, Douglas W. Blayney, MD, a medical oncologist, is the Ann and John Doerr Medical Director of the Stanford Cancer Center and a Professor at Stanford University School of Medicine. He is an ASCO Past President and a member of the Bylaws and Quality Care Committees and the Cost of Cancer Task Force.
  
Anees B. Chagpar, MD, MSc, MA, MPH, FACS, FRCS(C), a breast surgical oncologist, is Director of the Breast Center - Smilow Cancer Hospital at Yale-New Haven; Assistant Director of the Yale Cancer Center, responsible for Diversity and Health Equity; and Associate Professor in the Department of Surgery at Yale School of Medicine. She was part of the inaugural ASCO Leadership Development Program and has served as Chair of ASCO’s Innovation Grants Selection Committee and as a member of ASCO’s International Affairs Committee. Follow Dr. Chagpar on Twitter @AneesChagpar
   
John V. Cox, DO, MBA, FACP, FASCO, has been a member of Texas Oncology, P.A. since 1992 and serves on the teaching faculty for the internal medicine training program at Methodist Hospitals of Dallas. He is Chair-Elect of ASCO's Cancer Education Committee, the Editor-in-Chief of the Journal of Oncology Practice, and serves on the Ethics Committee. Dr. Cox is interested in new models/structures of care delivery.
   

Don S. Dizon, MD, FACP, is an Assistant in Medicine at Harvard Medical School and sees patients at the Gillette Center for Gynecologic Oncology at the Massachusetts General Hospital (MGH) Cancer Center, where he also is Founder and Director of the Oncology Sexual Health Clinic. Dr. Dizon serves on ASCO's Cancer Communications Committee. Dr. Dizon serves on ASCO's Cancer Communications Committee. In addition to his regular column on ASCOconnection.org, which won a 2013 Apex Grand Award, he is a blogger for MGH and Deputy Editor at UpToDate. Follow Dr. Dizon on Twitter @drdonsdizon.
  
Linda R. Duska, MDLinda R. Duska, MD, is an Associate Professor with tenure and the Fellowship Director for Gynecologic Oncology at the University of Virginia (UVA). She is an active member of the Gynecology Oncology Group, serving on multiple committees, as well as the author of several investigator-initiated clinical trials at UVA. Her research interests include the evaluation of novel therapeutics and targeted therapy for ovarian and endometrial cancers. She has a strong interest in health policy and is working toward a Master's degree in Public Health. Dr. Duska is active in the Foundation for Women's Cancers, where she is Chair of the Advocacy Board.
  
Michael Fisch, MD, MPH Michael Fisch, MD, MPH, is Chair of the Department of General Oncology at The University of Texas M. D. Anderson Cancer Center. His research interests include symptom management, palliative care, cardiotoxicity, and health care disparities. He previously served as Chair of ASCO's Integrated Media and Technology Committee. Follow Dr. Fisch on Twitter @fischmd.
   
Michael Fisch, MD, MPH Rob Fisher, MD, has been an ASCO member since 1991. He currently practices at the Longmont office of Rocky Mountain Cancer Centers in Colorado. Recognizing the need to provide online educational resources for breast cancer survivors and professionals, he is Co-Founder and is Organization President of the Pink Ribbon Survivors Network. This website hosts three separate online libraries: one for breast cancer survivors, one for cancer care professionals, and one for primary care providers. Dr. Fisher maintains an interest in strategies to improve the quality of survivorship care. Follow Dr. Fisher on Twitter @RobertEFisher1.
   
L. Michael Glodé, MD, FACP, FASCO, is a Professor in the Division of Medical Oncology at the School of Medicine at the University of Colorado Denver. He previously served as Chair of ASCO's Integrated Media and Technology and Cancer Education Committees.
   

David L. Graham, MD, is the Physician Administrator at Levine Cancer Center, in Charlotte, North Carolina. He is Chair of ASCO's Integrated Media and Technology Committee. His medical interests include genitourinary and hematologic malignancies and neuroendocrine tumors. Follow Dr. Graham on Twitter @davidgrahammd.
  

Clifford A. Hudis, MD, is the 2013-2014 President of ASCO. He is Chief of the Breast Cancer Medicine Service and an attending physician at Memorial Sloan-Kettering Cancer Center. He is also Professor in the Department of Medicine at Weill Cornell Medical College. His research interests include all areas of care related to breast cancer, with a focus on the development of novel systemic therapies. Follow Dr. Hudis on Twitter @CliffordHudis.
  
Heather M. Hylton, MS, PA-C, is the Lead Physician Assistant in the Department of Medicine at Memorial Sloan-Kettering Cancer Center. She serves on ASCO's Government Relations Committee and is an Associate Editor on the ASCO University Editorial Board. She is President of the Association of Physician Assistants in Oncology. Follow Ms. Hylton on Twitter @hmhyltonpac.
   
Abdul-Rahman Jazieh, MD, MPH Abdul-Rahman Jazieh, MD, MPH, is Chair of the Department of Oncology at King Abdulaziz Medical City and a Professor at King Saud bin Abdulaziz University for Health Sciences, National Guard Health Affairs, Riyadh, Saudi Arabia. Dr. Jazieh's areas of professional interest are lung cancer, professional development, and improvement of cancer care delivery. He is a member of ASCO's International Affairs Committee and International Development and Education Award (IDEA) Working Group. Follow Dr. Jazieh on Twitter @jaziehoncology.
   
Abdul-Rahman Jazieh, MD, MPH Matthew S. Katz, MD, is the Medical Director of Radiation Oncology at Lowell General Hospital and a partner in Radiation Oncology Associates, PA. He is an Instructor at Harvard Medical School and former Chair of Communications Committee for the American Society for Radiation Oncology (ASTRO). He serves on the Communications Committee for Massachusetts Medical Society and external advisory board for Mayo Clinic's Center for Social Media. His areas of prime interest are patient education and health empowerment. Follow Dr. Katz on Twitter @subatomicdoc.
   
Michael P. Link, MD, FASCO, is the Lydia J. Lee Professor in Pediatric Oncology at Stanford University School of Medicine. He is an ASCO Past President and current Chair of the Special Awards Selection Committee. His research interests include the biology and management of non-Hodgkin lymphoma and Hodgkin disease in children and the treatment of bone and soft-tissue sarcomas.
   
Abdul-Rahman Jazieh, MD, MPH William S. Loui, MD, FACP, is a medical oncologist in private practice in Hawaii. He is on the faculty at the University of Hawaii, John A. Burns School of Medicine. He has been honored by the Susan G. Komen for the Cure in Hawaii for his innovative work with minority breast cancer patients. He is Past President of the Hawaii Society of Clinical Oncology and has served the Society as a member of ASCO's Health Disparities Advisory Group, now the Health Disparities Committee.
   
Robert S. Miller, MD, FACP, FASCO, is a medical oncologist specializing in breast cancer and medical informatics at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. He is a former member of the ASCO Board of Directors. Follow Dr. Miller on Twitter @rsm2800.

 

   

Beverly Moy, MD, MPH, is the Clinical Director of the Breast Oncology Program and a medical oncologist at Massachusetts General Hospital. Her research interests include breast cancer clinical trials and racial and ethnic disparities in cancer care. Dr. Moy is a past Chair of ASCO's Advisory Group on Health Disparities and Ethics Committee. She currently serves on ASCO's Cancer Education Committee and Breast Cancer Consensus Panel. 



Richard T. Penson, MD, MRCP, is Associate Professor of Medicine at Harvard Medical School and Clinical Director of Medical Gynecologic Oncology at Massachusetts General Hospital. He is a faculty member teaching Patient Doctor I, for first year Harvard Medical students, and serves each year as an attending at Massachusetts General Hospital. He trained at St Bartholomew's (Bart's) and Guy's Hospitals in London and came to the U.S. in 1997. His oncology practice is devoted almost exclusively to gynecologic oncology with approximately a quarter of his patients treated on therapeutic clinical trials. Dr. Penson is one of the chairs for the Institutional Review Board for Dana-Farber/Partners CancerCare and sits on the Ovarian Committee for the National Comprehensive Cancer Network, and on the Gynecologic Oncology Group committee for Health Outcomes Research. He is on the Editorial Board of The Oncologist and Medical Humanities.
  
George W. Sledge, Jr., MD, FASCO, is the Ballve-Lantero Professor of Oncology and Professor of Medicine and Pathology at Indiana University Simon Cancer Center. His research interests include molecular and tumor biology, growth factors, and anti-angiogenic therapy related to breast cancer. Dr. Sledge is an ASCO Past President and currently serves as Chair of the Bylaws Committee.
  

Sandra M. Swain, MD, is the Medical Director of the Washington Cancer Institute at the MedStar Washington Hospital Center; a Professor of Medicine at Georgetown University; and an active member of the National Surgical Adjuvant Breast and Bowel Project (NSABP), serving as a member of the group's Board of Directors and Vice Chair of its Breast Committee. She is the Immediate Past President of ASCO and serves on the Finance and Special Awards Selection Committees and as the Chair of the Finance and Governance Subcommittee. Her research interests include evaluation of novel therapeutics and targeted therapy for locally advanced, specifically inflammatory breast cancer, and metastatic breast cancer.
   
Michael A. Thompson, MD, PhD Michael A. Thompson, MD, PhD, is a Hematologist/Oncologist for Aurora Cancer Care and is the Medical Director of Early Cancer Research at Aurora Health Care, in Wisconsin.  He participated in the ASCO Leadership Development Program and Integrated Media and Technology Committee. He currently serves on the ASCO Cancer Research Committee. Follow Dr. Thompson on Twitter @mtmdphd.
 
Peter Paul Yu, MD, FASCO, is a medical oncologist and hematologist, Director of Cancer Research at Palo Alto Medical Foundation, and a member of the Alliance for Clinical Trials in Oncology and the Gynecologic Oncology Group (GOG). He is ASCO President-Elect and Chair of the Research, Policy & Practice Subcommittee. Dr. Yu is ASCO Liaison to the College of American Pathologists Cancer Biomarker Reporting Committee and Past Chair of the ASCO HIT Working Group. Follow Dr. Yu on Twitter @YupOnc.
   
S. Yousuf Zafar, MD, MHS, is an Associate Professor and gastrointestinal oncologist at Duke Cancer Institute and the Duke Clinical Research Institute. He is a health services researcher with interests in the cost of care and how costs impact cancer patients' experiences. Dr. Zafar serves on ASCO's Health Disparities  Committee and the Quality Symposium Planning Committee. Follow Dr. Zafar on Twitter @yzafar.